HIGHLIGHTS
- who: Markus V. Heppt et al. from the Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nu00fcrnberg, Erlangen, Germany have published the Article: Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of /2022/
- what: In this study, it was reported for the first time that the time to maximal response was 3.2 months, suggesting that the patients` response peaked just slightly after their initial response. This study provides the first prospective evidence that MHC-I downregulation is a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.